Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional Accepts healthy volunteers

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age

ClinicalTrials.gov ID: NCT07742644

Public ClinicalTrials.gov record NCT07742644. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 10:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3a, Observer-blind, Randomized, Controlled Study to Demonstrate Lot-to-lot Consistency and Evaluate the Immunogenicity and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine Compared With ProQuad, Administered as a Second Dose in Healthy Children 4-6 Years of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate how consistently 3 different manufacturing lots of the GSK's investigational measles, mumps, rubella, and varicella (MMRVNS) vaccine will produce an immune response. It will also compare the overall immune response to the MMRVNS vaccine with that of the Merck licensed measles, mumps, rubella, and varicella (MMRV) vaccine. The vaccines will be given as a second dose to children aged 4 to 6 years who have previously received a first dose of any combination of measles, mumps, rubella, and varicella-containing vaccine(s). The study will also assess the immune response and safety of the MMRVNS and MMRV vaccines when given at the same time as a diphtheria, tetanus, acellular pertussis, and inactivated poliovirus (DTaP-IPV) vaccine. The DTaP-IPV vaccine used is licensed as Kinrix in the United States.

Study identification

NCT ID
NCT07742644
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
1,860 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years to 6 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2026
Primary completion
Jun 26, 2028
Completion
Nov 20, 2028
Last update posted
Aug 2, 2026

2026 – 2028

United States locations

U.S. sites
38
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
Children's Clinic of Jonesboro, AR Jonesboro Arkansas 72401
Applied Research Center of Arkansas Little Rock Arkansas 72212
Century Research Institute Inc Huntington Park California 90255
Matrix Clinical Research Los Angeles California 90057
Center for Clinical Trials of Sacramento, Inc. Sacramento California 95823
Center for Clinical Trials of San Gabriel West Covina California 91790
BioMD Clinical Research Coral Gables Florida 33134
D&H Pompano Research Center LLC Margate Florida 33063
PAS Research Tampa Florida 33613
Medical Research Partners Ammon Idaho 83406
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611-2605
Kentucky Pediatric/ Adult Research Bardstown Kentucky 40004
Norton Childrens Research Institute Louisville Kentucky 40202
Benchmark Research Covington Louisiana 70433
ACC Pediatric Research Haughton Louisiana 71037
Velocity Clinical Research, Gulfport Lafayette Louisiana 70508
Jefferson City Medical Group PC Jefferson City Missouri 65109
Boeson Research MSO Missoula Montana 59804
Midwest Children's Health Research Institute, LLC Lincoln Nebraska 68504
Midwest Children's Health Research Institute, LLC Lincoln Nebraska 68505
Complete Children's Health Lincoln Nebraska 68516
Complete Children's Health Lincoln Nebraska 68522-1231
Atrium Health Charlotte North Carolina 28203
Senders Pediatrics Cleveland Ohio 44121-4243
Neighbors Clinical Research Charleston South Carolina 29407
Tribe Clinical Research LLC/Parkside Pediatrics Greenville South Carolina 29607
Tribe Clinical Research LLC/Parkside Pediatrics Simpsonville South Carolina 29681
Carolina Family Care Summerville South Carolina 29486
Meharry Medical College Nashville Tennessee 37208
Tekton Research - Beaumont, TX Beaumont Texas 77706
Pas Research Edinburg Texas 78539
Pediatric Associates Houston Texas 77087
Tanner Clinic Kaysville Kaysville Utah 84037
Tanner Clinic Layton Parkway Layton Utah 84041
Ogden Clinic Canyon View Ogden Utah 84404
Pediatric Research of Charlottesville, LLC Charlottesville Virginia 22902
Clinical Research Partners, LLC Richmond Virginia 23236
Marshfield Clinic Research Foundation, a Division of Marshfield Clinic, Inc Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07742644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07742644 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →